Bio-Techne Corporation Financial Ratios — TECH Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	06/30/2011	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	06/30/2019	06/30/2020	06/30/2021	06/30/2022	06/30/2023	06/30/2024	06/30/2025

Return on Common Equity (%)	20.65	17.82	15.94	14.48	13.12	12.1	8.32	12.44	8.56	18.01	9.54	16.67	15.55	8.33	3.68
Return on Assets (%)	19.76	16.8	15.03	13.53	11.19	9.53	5.66	8.01	5.53	11.72	6.55	11.94	11.56	6.29	2.79
Return on Capital (%)	20.65	17.82	15.94	14.36	12.56	11.14	7.15	- -	7.43	14.07	8.11	14.48	13.24	7.43	3.29
Return on Invested Capital (%)	19.96	17.72	15.2	13.93	12.08	11.3	8.65	- -	8.14	7.07	11.99	12.8	10.98	9.07	7.45
Gross Margin (%)	77.57	74.96	74.41	70.27	67.94	67.46	66.53	67.21	66.31	65.41	67.97	68.42	67.72	66.41	64.8
EBITDA Margin (%)	58.44	56.13	54.29	49.47	41.37	38.95	36.34	34.78	31.55	31.35	35.49	35.9	35.03	30.9	28.92
Operating Margin (%)	55.44	52.16	50.32	44.11	33.13	30.38	25.68	24.76	20.6	20.15	26.07	26.76	25.6	21.26	19.91
Incremental Operating Margin (%)	31.72	13.5	195.86	3.25	-8.43	3.73	-11	18.28	-17.01	7.06	48.79	30.44	-15.53	-199.47	-5.94
Pretax Margin (%)	56.9	51.56	51.73	45.11	34.09	29.55	19.89	19.59	15.69	37.43	15.92	27.26	29.79	16.02	8.07
Profit Margin (%)	38.73	35.71	36.24	31.01	23.82	20.94	13.51	19.62	13.46	31.04	15.08	24.61	25.1	14.5	6.02
Net Income to Common Margin (%)	38.73	35.71	36.24	31.01	23.82	20.94	13.51	19.62	13.46	31.04	15.08	24.61	25.1	14.5	6.02
Effective Tax Rate (%)	31.93	30.74	29.94	31.26	30.12	29.16	32.04	- -	14.23	17.07	5.8	12.7	15.71	9.47	25.45
Dvd Payout Ratio (%)	35.34	36.52	38.61	40.91	43.72	45.57	62.2	38.03	50.34	21.33	35.76	19.75	17.61	29.99	68.65
Sustainable Growth Rate (%)	13.35	11.31	9.79	8.55	7.38	6.59	3.15	7.71	4.25	14.17	6.13	13.38	12.81	5.83	1.15

Credit (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	06/30/2011	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	06/30/2019	06/30/2020	06/30/2021	06/30/2022	06/30/2023	06/30/2024	06/30/2025

Total Debt	- -	- -	- -	13	77	95	344	339	505	434	421	326	455	420	444
ST Debt	- -	- -	- -	6	4	4	- -	- -	12	22	24	24	11	13	14
LT Debt	- -	- -	- -	7	73	92	344	339	493	411	396	302	444	407	430
Total Debt/EBITDA	- -	- -	- -	0.07	0.41	0.49	1.68	1.52	2.24	1.87	1.27	0.82	1.14	1.17	1.26
Net Debt/EBITDA	-0.46	-0.66	-0.97	-1.73	0.12	0.16	1.23	0.97	1.79	0.91	0.43	0.21	0.43	0.47	0.52
Total Debt/EBIT	- -	- -	- -	0.08	0.51	0.63	2.38	2.13	3.43	2.91	1.73	1.1	1.56	1.7	1.83
Net Debt/EBIT	-0.48	-0.71	-1.05	-1.94	0.15	0.2	1.74	1.36	2.75	1.41	0.59	0.28	0.58	0.68	0.76
EBITDA to Interest Expense	- -	- -	- -	- -	121.16	111.19	27.79	21.95	10.38	12.06	23.68	35.1	35.51	22.76	41.45
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	108.27	101.52	25.73	19.9	9.21	9.37	20.51	31.12	32.1	18.76	37.81
EBIT to Interest Expense	- -	- -	- -	- -	97.05	86.72	19.64	15.62	6.78	7.75	17.39	26.16	25.95	15.66	28.53
Interest Expense	- -	- -	- -	- -	2	2	7	10	22	19	14	11	11	16	9
Common Equity/Total Assets	94.89	93.76	94.79	92.21	79.65	77.84	60.94	67.73	61.85	68.12	69.07	74.16	74.53	76.51	75.02
Long-Term Debt/Equity (%)	- -	- -	- -	0.88	8.62	10.41	36.2	31.42	42.27	29.79	25.23	17.73	22.57	19.65	22.41
Long-Term Debt/Capital (%)	- -	- -	- -	0.87	7.9	9.39	26.58	23.91	29.49	22.68	19.9	14.88	18.33	16.34	18.2
Long-Term Debt/Total Assets (%)	- -	- -	- -	0.81	6.87	8.1	22.06	21.28	26.14	20.29	17.52	13.14	16.82	15.04	16.81
Total Debt/Equity (%)	- -	- -	- -	1.63	9.09	10.83	36.2	31.42	43.34	31.39	26.77	19.16	23.14	20.28	23.14
Total Debt/Capital (%)	- -	- -	- -	1.6	8.34	9.77	26.58	23.91	30.24	23.89	21.11	16.08	18.79	16.86	18.79
Total Debt/Total Assets (%)	- -	- -	- -	1.5	7.24	8.43	22.06	21.28	26.81	21.38	18.58	14.2	17.24	15.52	17.36
Net Debt to Equity	-13.24	-17.3	-22.21	-38.43	2.66	3.53	26.55	20.11	34.68	15.21	9.05	4.9	8.62	8.08	9.58
Net Debt/Capital (%)	-15.26	-20.92	-28.55	-62.42	2.59	3.41	20.98	16.74	25.75	12.6	7.93	4.49	7.56	7.16	8.35
EBITDA	169	177	169	177	187	194	205	224	225	232	330	397	398	358	353
EBITDA-CapEx	166	171	146	163	167	177	189	203	200	180	286	352	360	295	322
Operating Income (Loss)	161	164	156	158	150	152	145	159	147	149	243	296	291	246	243

Liquidity (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	06/30/2011	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	06/30/2019	06/30/2020	06/30/2021	06/30/2022	06/30/2023	06/30/2024	06/30/2025

Cash Ratio	7.74	7.52	10.38	13.77	2.79	1.77	1.16	2.29	1.63	2.54	1.52	1.4	1.59	0.96	0.92
Current Ratio	12.67	9.69	12.76	17.79	6.24	4.69	2.57	5.01	4.05	4.88	3.35	3.44	4.84	3.87	3.46
Quick Ratio	9.82	8.58	11.63	15.85	4.55	3.49	2.03	3.8	2.98	3.69	2.48	2.51	3.29	2.47	2.1
CFO/Avg Current Liab	7.22	4.7	3.64	4.68	4.21	3.07	1.52	1.58	2	1.97	2.72	1.98	1.67	2.08	1.72
Common Equity/Total Assets	94.89	93.76	94.79	92.21	79.65	77.84	60.94	67.73	61.85	68.12	69.07	74.16	74.53	76.51	75.02
Long-Term Debt/Equity (%)	- -	- -	- -	0.88	8.62	10.41	36.2	31.42	42.27	29.79	25.23	17.73	22.57	19.65	22.41
Long-Term Debt/Capital (%)	- -	- -	- -	0.87	7.9	9.39	26.58	23.91	29.49	22.68	19.9	14.88	18.33	16.34	18.2
Long-Term Debt/Total Assets (%)	- -	- -	- -	0.81	6.87	8.1	22.06	21.28	26.14	20.29	17.52	13.14	16.82	15.04	16.81
Total Debt/Equity (%)	- -	- -	- -	1.63	9.09	10.83	36.2	31.42	43.34	31.39	26.77	19.16	23.14	20.28	23.14
Total Debt/Capital (%)	- -	- -	- -	1.6	8.34	9.77	26.58	23.91	30.24	23.89	21.11	16.08	18.79	16.86	18.79
Total Debt/Total Assets (%)	- -	- -	- -	1.5	7.24	8.43	22.06	21.28	26.81	21.38	18.58	14.2	17.24	15.52	17.36
CFO/Total Liabilities	403.18	282.4	304.66	203.44	64.39	57.59	23.62	33.14	25.27	31.75	50.91	54.78	37.85	47.08	45
CFO/CapEx	35.04	21.06	5.5	9.9	7	8.53	9.47	8.14	7.15	3.97	7.95	7.24	6.65	4.76	9.27
Altman's Z-Score	62.53	39.86	40.86	34.43	15.93	16.04	8.91	11.56	11.63	13.52	19.79	18.15	15.16	14.29	10.81

Working Capital (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	06/30/2011	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	06/30/2019	06/30/2020	06/30/2021	06/30/2022	06/30/2023	06/30/2024	06/30/2025

Accounts Receivable Turnover	8.69	8.79	8.41	7.68	7.23	6.11	5.36	5.42	5.54	5.68	6.95	6.5	5.5	5.04	5.44
Days Sales Outstanding	42.02	41.53	43.4	47.53	50.46	59.77	68.14	67.3	65.88	64.24	52.52	56.11	66.31	72.41	67.08
Inventory Turnover	2.22	1.89	2.17	2.89	3.28	3.04	3.21	2.89	2.72	2.63	2.71	2.71	2.35	2.22	2.33
Days Inventory Outstanding	164.59	192.76	168.01	126.51	111.32	119.91	113.54	126.2	134.08	138.72	134.59	134.81	155.58	164.7	156.92
Accounts Payable Turnover	18.43	12.55	12.14	13.89	13.48	9.97	10.21	13.39	14.19	13.62	11.88	11.81	13.35	12.49	13.88
Accounts Payable Turnover Days	19.8	29.09	30.06	26.28	27.07	36.63	35.74	27.26	25.72	26.8	30.72	30.91	27.34	29.23	26.3
Cash Conversion Cycle	186.8	205.2	181.35	147.76	134.7	143.05	145.94	166.23	174.24	176.15	156.39	160.01	194.54	207.88	197.69
Inventory to Cash Days	-122.57	-151.23	-124.61	-78.98	-60.86	-60.14	-45.4	-58.89	-68.19	-74.48	-82.07	-78.69	-89.27	-92.3	-89.84
Inventories	45	38	35	39	50	57	60	86	91	103	117	141	172	180	189
Raw Materials	6	6	6	10	16	19	22	31	41	52	55	79	85	79	89
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	39	33	29	29	34	38	38	55	50	52	62	62	87	100	100
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	06/30/2011	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	06/30/2019	06/30/2020	06/30/2021	06/30/2022	06/30/2023	06/30/2024	06/30/2025

Market Capitalization	3,097	2,733	2,545	3,425	3,659	4,201	4,390	5,564	7,908	10,155	17,541	13,574	12,868	11,336	7,973
- Cash & Cash Equivalents	78	117	164	319	55	64	92	122	101	147	199	173	181	152	162
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	8	-1	- -	- -	- -
+ Total Debt	- -	- -	- -	13	77	95	344	339	505	434	421	326	455	420	444
Enterprise Value	2,956	2,464	2,212	3,075	3,625	4,200	4,576	5,722	8,248	10,317	17,738	13,653	13,119	11,603	8,255
Total Capital	586	674	738	808	924	975	1,293	1,418	1,671	1,815	1,992	2,027	2,421	2,488	2,363
Total Debt/Capital (%)	- -	- -	- -	1.6	8.34	9.77	26.58	23.91	30.24	23.89	21.11	16.08	18.79	16.86	18.79
Total Debt / EV	- -	- -	- -	- -	0.02	0.02	0.08	0.06	0.06	0.04	0.02	0.02	0.03	0.04	0.05
EV/Sales	10.2	7.83	7.12	8.59	8.02	8.42	8.13	8.9	11.55	13.97	19.05	12.35	11.54	10.01	6.77
EV/EBITDA	17.45	13.95	13.12	17.37	19.38	21.61	22.37	25.58	36.61	44.55	53.68	34.4	32.94	32.4	23.41
EV/EBIT	18.39	15.01	14.15	19.48	24.19	27.71	31.66	35.94	56.07	69.31	73.09	46.15	45.08	47.09	34
EV/Cash Flow to Firm	23.24	19.44	17.9	22.48	25.81	28.89	30.77	31.69	41.19	46.66	48.56	40.74	49.72	37.04	28.09
EV/Free Cash Flow to Firm	22.6	18.56	15.15	20.42	22.61	25.88	27.92	28.39	36.55	37.81	43.31	35.92	43.43	30.85	25.41
Diluted Market Cap	3,099	2,746	2,549	3,425	3,667	4,209	4,407	5,631	8,108	10,405	18,229	14,222	13,212	11,519	8,217
Diluted Enterprise Value	3,021	2,629	2,385	3,120	3,689	4,240	4,659	5,848	8,512	10,692	18,458	14,375	13,487	11,787	8,499
EV per Share	19.89	16.72	15.01	20.77	24.39	28.19	30.63	38.04	54.35	67.08	113.84	87.16	83.22	73.34	53.27
TTM Sales	290	315	311	358	452	499	563	643	714	739	931	1,106	1,137	1,159	1,220
TTM EBITDA	169	177	169	177	187	194	205	224	225	232	330	397	398	358	353
TTM Operating Income	161	164	156	158	150	152	145	159	147	149	243	296	291	246	243
TTM Cash Flow to Firm	127	127	124	137	140	145	149	181	200	221	365	335	264	313	294
TTM Free Cash Flow to Firm	131	133	146	151	160	162	164	202	226	273	410	380	302	376	325

Multiples (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	06/30/2011	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	06/30/2019	06/30/2020	06/30/2021	06/30/2022	06/30/2023	06/30/2024	06/30/2025

Price/Free Cash Flow	23.69	20.68	17.46	22.75	23.02	26.13	27.73	29.43	39.16	40.49	45.98	38.42	45.15	31.83	25.8
EV/EBIT	18.39	15.01	14.15	19.48	24.19	27.71	31.66	35.94	56.07	69.31	73.09	46.15	45.08	47.09	34
Enterprise Value	2,956	2,464	2,212	3,075	3,625	4,200	4,576	5,722	8,248	10,317	17,738	13,653	13,119	11,603	8,255
Low Price	13.91	15.51	15.64	17.33	21.5	19.99	23.92	28.08	33.19	38.79	57.17	79.52	68	51.79	46.01
EV/Sales	10.2	7.83	7.12	8.59	8.02	8.42	8.13	8.9	11.55	13.97	19.05	12.35	11.54	10.01	6.77
EV/EBITDA	17.45	13.95	13.12	17.37	19.38	21.61	22.37	25.58	36.61	44.55	53.68	34.4	32.94	32.4	23.41
Price/Earnings	27.54	24.4	22.61	30.78	33.91	40.14	57.63	43.96	81.99	44	124.26	49.97	44.98	67.22	110.41
Price/Earnings Average	22.24	22.99	22.58	28.32	32.73	34.07	52.43	40.1	71.36	35.4	91.96	63.71	44.55	68.03	143.27
Price/Earnings High	27.7	28.42	24.88	32.24	35.66	40.8	58.85	49.55	85.13	47.07	125.24	78.4	54.74	84.35	179.45
Price/Earnings Low	18.38	20.4	20.47	23.05	29.61	28.47	46.92	33.37	52.21	25.85	63.11	45.85	37.47	48.59	98.74
Price/Book Value	5.28	4.05	3.45	4.31	4.32	4.78	4.62	5.16	6.78	7.35	11.22	7.98	6.54	5.48	4.16
Price/Book Value Average	4.27	3.82	3.45	3.96	4.17	4.05	4.21	4.7	5.91	5.92	8.31	10.17	6.48	5.55	5.39
Price/Book Value High	5.31	4.72	3.8	4.51	4.54	4.86	4.72	5.81	7.05	7.87	11.31	12.51	7.96	6.88	6.75
Price/Book Value Low	3.53	3.39	3.12	3.23	3.77	3.39	3.76	3.91	4.32	4.32	5.7	7.32	5.45	3.96	3.72
Price/Tangible Book Value	6.93	5.04	4.15	6.4	22.38	30.47	-53.91	159.72	-53.98	74.48	168.77	38.99	23.01	19.24	13.93
Price/Tangible Book Value Average	5.59	4.75	4.15	5.89	21.6	25.86	-49.04	145.71	-46.99	59.94	124.9	49.71	22.8	19.47	18.08
Price/Tangible Book Value High	6.97	5.87	4.57	6.71	23.54	30.97	-55.04	180.05	-56.05	79.68	170.1	61.17	28.01	24.15	22.64
Price/Tangible Book Value Low	4.62	4.21	3.76	4.79	19.55	21.61	-43.89	121.25	-34.37	43.76	85.71	35.78	19.17	13.91	12.46
Price/Sales	10.67	8.71	8.19	9.54	8.08	8.4	7.79	8.62	11.03	13.66	18.74	12.3	11.29	9.75	6.64
Price/Sales Average	8.61	8.21	8.18	8.78	7.8	7.13	7.09	7.87	9.6	10.99	13.87	15.68	11.18	9.87	8.62
Price/Sales High	10.73	10.15	9.02	10	8.49	8.54	7.95	9.72	11.45	14.61	18.89	19.29	13.74	12.23	10.8
Price/Sales Low	7.12	7.29	7.42	7.15	7.05	5.96	6.34	6.55	7.02	8.02	9.52	11.28	9.4	7.05	5.94
Price/Cash Flow	24.31	21.62	20.59	24.97	26.21	29.09	30.51	32.55	43.37	49.16	49.54	41.8	50.44	37.79	28.18
Price/Cash Flow Average	19.63	20.38	20.57	22.98	25.3	24.69	27.76	29.69	37.75	39.56	36.67	53.29	49.96	38.25	36.57
Price/Cash Flow High	24.45	25.19	22.67	26.15	27.57	29.57	31.15	36.69	45.03	52.59	49.93	65.57	61.38	47.43	45.81
Price/Cash Flow Low	16.23	18.08	18.65	18.7	22.89	20.63	24.84	24.71	27.62	28.88	25.16	38.35	42.01	27.32	25.2
Price/Free Cash Flow Average	19.13	19.49	17.44	20.93	22.22	22.18	25.23	26.85	34.09	32.58	34.03	48.98	44.72	32.22	33.47
Price/Free Cash Flow High	23.82	24.09	19.22	23.83	24.21	26.56	28.32	33.18	40.67	43.32	46.34	60.28	54.94	39.95	41.92
Price/Free Cash Flow Low	15.81	17.29	15.81	17.04	20.1	18.53	22.58	22.34	24.94	23.79	23.35	35.25	37.61	23.01	23.07
EV/Sales Average	8.36	7.81	7.66	7.96	7.86	7.21	7.54	8.23	10.21	11.45	14.19	15.79	11.46	10.13	8.71
EV/Sales High	10.47	9.75	8.49	9.17	8.56	8.62	8.41	10.09	12.07	15.1	19.24	19.4	14.02	12.5	10.86
EV/Sales Low	6.86	6.89	6.89	6.32	7.11	6.03	6.8	6.91	7.62	8.47	9.81	11.4	9.67	7.3	6.08
EV/EBITDA Average	14.3	13.92	14.1	16.08	19	18.5	20.75	23.67	32.35	36.52	39.98	43.99	32.7	32.78	30.13
EV/EBITDA High	17.92	17.37	15.64	18.54	20.69	22.13	23.14	29.02	38.25	48.15	54.2	54.04	40.01	40.47	37.54
EV/EBITDA Low	11.74	12.28	12.7	12.77	17.2	15.49	18.7	19.86	24.15	27	27.65	31.77	27.61	23.63	21.02
EV/EBIT Average	15.07	14.98	15.22	18.04	23.72	23.72	29.37	33.25	49.54	56.83	54.44	59.02	44.75	47.65	43.77
EV/EBIT High	18.89	18.69	16.87	20.8	25.83	28.37	32.75	40.77	58.57	74.91	73.79	72.51	54.76	58.82	54.53
EV/EBIT Low	12.38	13.21	13.7	14.32	21.47	19.85	26.47	27.9	36.98	42.01	37.65	42.62	37.78	34.34	30.53
Last Price	20.84	18.55	17.27	23.14	24.62	28.19	29.38	36.99	52.12	66.02	112.57	86.66	81.63	71.65	51.45
High Price	20.96	21.61	19.01	24.24	25.89	28.65	30	41.7	54.12	70.63	113.46	135.96	99.34	89.91	83.62
Enterprise Value Average	2,423	2,458	2,378	2,846	3,554	3,596	4,246	5,294	7,288	8,458	13,211	17,459	13,021	11,740	10,628
Enterprise Value High	3,037	3,067	2,637	3,282	3,870	4,300	4,735	6,490	8,616	11,151	17,909	21,449	15,935	14,493	13,241
Enterprise Value Low	1,990	2,168	2,141	2,259	3,218	3,010	3,826	4,441	5,440	6,253	9,138	12,609	10,994	8,462	7,412

Shares Outstanding	149	147	147	148	149	149	149	150	152	154	156	157	158	158	155
Diluted Weighted Avg Shares	149	148	148	148	149	149	150	152	156	158	162	164	162	161	160
Basic Weighted Avg Shares	148	148	147	148	148	149	149	150	151	153	155	157	157	158	158
Revenue per Share	1.95	2.13	2.11	2.42	3.05	3.35	3.77	4.29	4.72	4.83	6.01	7.05	7.23	7.35	7.74
EBITDA per Share	1.14	1.19	1.14	1.2	1.26	1.31	1.37	1.49	1.49	1.52	2.13	2.53	2.53	2.27	2.24
Operating Income per Share	1.08	1.11	1.06	1.07	1.01	1.02	0.97	1.06	0.97	0.97	1.57	1.89	1.85	1.56	1.54
Basic EPS, GAAP	0.76	0.76	0.76	0.75	0.73	0.7	0.51	0.84	0.64	1.5	0.91	1.73	1.81	1.07	0.47
Basic EPS from Cont Ops	0.76	0.76	0.76	0.75	0.73	0.7	0.51	0.84	0.64	1.5	0.9	1.68	1.82	1.07	0.47
Diluted EPS, GAAP	0.76	0.76	0.76	0.75	0.72	0.7	0.51	0.83	0.62	1.45	0.87	1.66	1.76	1.05	0.46
Diluted EPS from Cont Ops	0.76	0.76	0.76	0.75	0.72	0.7	0.51	0.83	0.62	1.45	0.86	1.6	1.76	1.05	0.46
Dividend per Share	0.27	0.28	0.29	0.31	0.32	0.32	0.32	0.32	0.32	0.32	0.32	0.32	0.32	0.32	0.32
Cash Flow per Share	0.86	0.86	0.84	0.93	0.94	0.97	0.96	1.14	1.2	1.34	2.27	2.07	1.62	1.9	1.83
Free Cash Flow per Basic Share	0.83	0.82	0.69	0.83	0.81	0.86	0.86	1	1.03	1	1.99	1.79	1.38	1.5	1.63
Cash & Equivalents per Share	0.95	1.83	2.26	2.45	0.75	0.64	1.06	1.21	1.09	1.76	1.49	1.58	1.3	0.97	1.05
Book Value per Share	3.94	4.58	5.01	5.37	5.7	5.9	6.36	7.17	7.68	8.98	10.03	10.86	12.47	13.08	12.38
Tangible Book Value per Share	3.01	3.68	4.16	3.61	1.1	0.93	-0.55	0.23	-0.97	0.89	0.67	2.22	3.55	3.72	3.69

Bio-Techne Corporation

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)